1. Immune surveillance of tumors;Swann;J Clin Invest,2007
2. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012
3. Maintenance therapy in NSCLC: why? to whom? Which agent?;Novello;J Exp Clin Cancer Res,2011
4. Five-year follow-up from the CA209-003 study of nivolumab in previously treated advanced non-small cell lung cancer: clinical characteristics of long-term survivors;Brahmer,2017
5. Immune-checkpoint inhibitors in non-small cell lung cancer: a tool to improve patients' selection;Banna;Crit Rev Oncol Hematol,2018